Telomir Pharmaceuticals, Inc. Common Stock (TELO) Earnings Analysis
Telomir Pharmaceuticals, Inc. Common Stock (TELO) next reports earnings on 2026-09-02, consensus EPS -0.07 USD. Last quarter (2026-03-17) it beat with EPS -0.06 USD vs -0.07 USD est (+14.3%). It has beaten estimates in 2/3 recent quarters (67%). Trailing P/E -3.61.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does TELO next report earnings?
| Next earnings date | 2026-09-02 |
|---|---|
| Consensus EPS estimate | -0.07 USD |
| Revenue estimate | n/a |
TELO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-17 | -0.06 USD | -0.07 USD | +14.3% | Beat |
| 2025-11-10 | -0.03 USD | -0.07 USD | +57.1% | Beat |
| 2025-08-14 | -0.17 USD | -0.08 USD | -112.5% | Miss |
Beat rate: 2/3 (67%) over reported quarters with consensus data.
TELO valuation and analyst view
| Trailing P/E | -3.61 |
|---|---|
| Trailing EPS | -0.2683 USD |
| Price / book | 7.34 |
| Dividend yield | 0.00% |
| Market cap | 0.04B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Telomir Pharmaceuticals, Inc. Common Stock (TELO)'s next earnings date?
Telomir Pharmaceuticals, Inc. Common Stock is next scheduled to report on 2026-09-02, with a consensus EPS estimate of -0.07 USD.
Did TELO beat earnings last quarter?
In its 2026-03-17 report, TELO posted EPS of -0.06 USD versus a -0.07 USD estimate — a beat of 14.3%.
What is TELO's earnings track record?
Over the last 3 reported quarters with consensus data, TELO beat estimates 2 times (67%).
What is TELO's current P/E ratio and EPS?
TELO trades at a trailing P/E of -3.61 on trailing EPS of -0.2682973671686003 USD.
What do analysts rate TELO?
TELO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.